<p xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Par6">Among patients diagnosed with AIS within 30 days of COVID-19 infection, all-cause mortality was significantly lower in the vaccinated cohort compared to the unvaccinated cohort at 7 days (3.3% vs 5.0%; HR&#8201;=&#8201;0.66; 95% CI&#8201;=&#8201;0.52&#8211;0.83) and 30 days (8.2% vs 9.5%; HR&#8201;=&#8201;0.83; 95% CI&#8201;=&#8201;0.71&#8211;0.97) after AIS (Table <xref rid="Tab2" ref-type="table">2</xref>, Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Vaccinated patients also had lower rates of intracranial hemorrhage [7 days: 4.1% vs 6.2%; HR&#8201;=&#8201;0.66; 95% CI&#8201;=&#8201;0.53&#8211;0.82 and 30 days: 4.5% vs 6.7%; HR&#8201;=&#8201;0.66; 95% CI&#8201;=&#8201;0.53&#8211;0.81)], venous thromboembolism [7 days: 3.5% vs 7.8%; HR&#8201;=&#8201;0.44; 95% CI&#8201;=&#8201;0.35&#8211;0.56 and 30 days: 4.6% vs 8.9%; HR&#8201;=&#8201;0.51; 95% CI&#8201;=&#8201;0.41&#8211;0.63)] and acute myocardial infarction [7 days: 4.1% vs 7.0%; HR&#8201;=&#8201;0.58; 95% CI&#8201;=&#8201;0.46&#8211;0.73 and 30 days: 4.7% vs 7.6%; HR&#8201;=&#8201;0.60; 95% CI&#8201;=&#8201;0.49&#8211;0.75)] (Table <xref rid="Tab2" ref-type="table">2</xref>, Fig. <xref rid="Fig1" ref-type="fig">1</xref>). There was no significant difference in the rates of mechanical ventilation and <italic>G</italic>-tube placement at 7 and 30 days between the two groups (Table <xref rid="Tab2" ref-type="table">2</xref>, Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Outcomes of COVID-19-associated AIS cases with and without COVID-19 vaccination.</title><p>Comparison of outcomes at 7 and 30 days between propensity-score matched COVID-19-associated AIS cases in the exposure (vaccinated) and control (unvaccinated) cohorts.</p></caption><graphic xlink:href="41541_2025_1158_Fig1_HTML" id="d33e892"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>7- and 30-days outcome in propensity-matched COVID-19-associated stroke cases with and without vaccination</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="3">All patients in study</th><th colspan="3">Pfizer subgroup</th><th colspan="3">Moderna subgroup</th></tr><tr><th/><th>Vaccinated <italic>N</italic>&#8201;=&#8201;3,569 Events / Subjects (% Risk)</th><th>Unvaccinated <italic>N</italic>&#8201;=&#8201;3,569 Events / Subjects (% Risk)</th><th>HR (95% CI), P value, log rank test</th><th>Vaccinated <italic>N</italic>&#8201;=&#8201;2,453 Events / Subjects (% Risk)</th><th>Unvaccinated <italic>N</italic>&#8201;=&#8201;2,453 Events / Subjects (% Risk)</th><th>HR (95% CI) P value</th><th>Vaccinated N&#8201;=&#8201;997 Events / Subjects (% Risk)</th><th>Unvaccinated N&#8201;=&#8201;997 Events / Subjects (% Risk)</th><th>HR (95% CI) P value</th></tr></thead><tbody><tr><td colspan="10"><bold>7 days outcomes</bold></td></tr><tr><td>&#8195;All-cause mortality</td><td>119 / 3569 (3.3%)</td><td>179 / 3569 (5.0%)</td><td>0.66 (0.52, 0.83)</td><td>77 / 2453 (3.1%)</td><td>107 / 2453 (4.4%)</td><td>0.71 (0.53, 0.95)</td><td>41 / 997 (4.1%)</td><td>41 / 997 (4.1%)</td><td>0.99 (0.64, 1.52)</td></tr><tr><td>&#8195;Intracranial hemorrhage*</td><td>133 / 3269 (4.1%)</td><td>203 / 3294 (6.2%)</td><td>0.66 (0.53, 0.82)</td><td>87 / 2256 (3.9%)</td><td>139 / 2264 (6.1%)</td><td>0.62 (0.48, 0.81)</td><td>45 / 909 (5.0%)</td><td>53 / 910 (5.8%)</td><td>0.85 (0.60, 1.30)</td></tr><tr><td>&#8195;Venous thromboembolic events*</td><td>98 / 2806 (3.5%)</td><td>225 / 2874 (7.8%)</td><td>0.44 (0.35, 0.56)</td><td>59 / 1979 (3.0%)</td><td>150 / 2031 (7.4%)</td><td>0.40 (0.29, 0.54)</td><td>39 / 749 (5.2%)</td><td>46 / 755 (6.1%)</td><td>0.85 (0.56, 1.31)</td></tr><tr><td>&#8195;Acute myocardial infarction*</td><td>118 / 2876 (4.1%)</td><td>205 / 2941 (7.0%)</td><td>0.58 (0.46, 0.73)</td><td>67 / 2016 (3.3%)</td><td>149 / 2061 (7.2%)</td><td>0.45 (0.34, 0.60)</td><td>47 / 773 (6.1%)</td><td>65 / 798 (8.1%)</td><td>0.74 (0.51, 1.08)</td></tr><tr><td>&#8195;<italic>G</italic>-tube placement*</td><td>15 / 3501 (0.4%)</td><td>21 / 3528 (0.6%)</td><td>0.71 (0.37, 1.38)</td><td>12 / 2406 (0.5%)</td><td>12 / 2428 (0.5%)</td><td>1.00 (0.45, 2.23)</td><td>10 / 982 (1.0%)</td><td>10 / 988 (1.0%)</td><td>0.33 (0.07, 1.64)</td></tr><tr><td>&#8195;Mechanical ventilation*</td><td>153 / 3299 (4.6%)</td><td>175 / 3383 (5.2%)</td><td>0.89 (0.72, 1.11)</td><td>105 / 2248 (4.7%)</td><td>141 / 2321 (6.1%)</td><td>0.76 (0.59, 0.98)</td><td>56 / 938 (6.0%)</td><td>44 / 942 (4.7%)</td><td>1.3 (0.86, 1.90)</td></tr><tr><td colspan="10"><bold>30-days outcomes</bold></td></tr><tr><td>&#8195;All-cause mortality</td><td>294 / 3569 (8.2%)</td><td>339 / 3569 (9.5%)</td><td>0.83 (0.71, 0.97)</td><td>192 / 2453 (7.8%)</td><td>217 / 2453 (8.8%)</td><td>0.85 (0.70, 1.03)</td><td>97 / 997 (9.7%)</td><td>96 / 997 (9.6%)</td><td>0.98 (0.74, 1.29)</td></tr><tr><td>&#8195;Intracranial hemorrhage*</td><td>147 / 3269 (4.5%)</td><td>222 / 3294 (6.7%)</td><td>0.66 (0.53, 0.81)</td><td>98 / 2256 (4.3%)</td><td>149 / 2264 (6.6%)</td><td>0.65 (0.50, 0.84)</td><td>47 / 909 (5.2%)</td><td>57 / 910 (6.3%)</td><td>0.82 (0.56, 1.20)</td></tr><tr><td>&#8195;Venous thromboembolic events*</td><td>130 / 2806 (4.6%)</td><td>255 / 2874 (8.9%)</td><td>0.51 (0.41, 0.63)</td><td>81 / 1979 (4.1%)</td><td>178 / 2031 (8.8%)</td><td>0.45 (0.35, 0.59)</td><td>48 / 749 (6.4%)</td><td>60 / 755 (7.9%)</td><td>0.79 (0.54, 1.16)</td></tr><tr><td>&#8195;Acute myocardial infarction*</td><td>134 / 2876 (4.7%)</td><td>223 / 2941 (7.6%)</td><td>0.60 (0.49, 0.75)</td><td>75 / 2016 (3.7%)</td><td>162 / 2061 (7.9%)</td><td>0.46 (0.35, 0.61)</td><td>54 / 773 (7.0%)</td><td>68 / 798 (8.5%)</td><td>0.81 (0.57, 1.16)</td></tr><tr><td>&#8195;<italic>G</italic>-tube placement*</td><td>57 / 3501 (1.6%)</td><td>64 / 3528 (1.8%)</td><td>0.86 (0.60, 1.23)</td><td>40 / 2406 (1.7%)</td><td>45 / 2428 (1.9%)</td><td>0.86 (0.56, 1.32)</td><td>14 / 982 (1.4%)</td><td>14 / 988 (1.4%)</td><td>0.96 (0.46, 2.02)</td></tr><tr><td>&#8195;Mechanical ventilation*</td><td>186 / 3299 (5.6%)</td><td>202 / 3383 (6.0%)</td><td>0.93 (0.76, 1.14)</td><td>129 / 2248 (5.7%)</td><td>163 / 2321 (7.0%)</td><td>0.80 (0.64, 1.01)</td><td>67 / 938 (7.1%)</td><td>53 / 942 (5.6%)</td><td>1.3 (0.88, 1.82)</td></tr></tbody></table><table-wrap-foot><p><sup>*</sup>The denominator is less than the total number listed in the column header due to exclusion of patients who had a outcome of interest before the index stroke. New outcome of interest that occurred only after the index stroke were calculated.</p></table-wrap-foot></table-wrap></p>